IRMD Iradimed Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRMD

Price (delayed)

$43.94

Market cap

$553.89M

P/E Ratio

34.06

Dividend/share

$1.05

EPS

$1.29

Enterprise value

$509.29M

IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging ('MRI') compatible medical devices. It's the only known provider of a non-magnetic intravenous ('IV') infusion pump system ...

Highlights
IRMD's price to earnings (P/E) is 47% lower than its 5-year quarterly average of 63.9 and 2.4% lower than its last 4 quarters average of 34.9
Iradimed's net income has increased by 25% YoY and by 11% from the previous quarter
Iradimed's quick ratio has decreased by 36% YoY
Iradimed's gross margin has decreased by 2.4% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.iradimed.com
Peers: COO DXCM EW

Key stats

What are the main financial stats of IRMD
Market
Shares outstanding
12.61M
Market cap
$553.89M
Enterprise value
$509.29M
Valuations
Price to earnings (P/E)
34.06
Price to book (P/B)
7.43
Price to sales (P/S)
8.79
EV/EBIT
24.53
EV/EBITDA
24.69
EV/Sales
8.09
Earnings
Revenue
$62.97M
EBIT
$20.76M
EBITDA
$20.63M
Free cash flow
$4.75M
Per share
EPS
$1.29
Free cash flow per share
$0.38
Book value per share
$5.92
Revenue per share
$5
TBVPS
$6.74
Balance sheet
Total assets
$87.41M
Total liabilities
$12.84M
Debt
$2.15M
Equity
$74.57M
Working capital
$64.05M
Liquidity
Debt to equity
0.03
Current ratio
9.13
Quick ratio
7.55
Net debt/EBITDA
-2.16
Margins
EBITDA margin
32.8%
Gross margin
76.2%
Net margin
25.9%
Operating margin
30.4%
Efficiency
Return on assets
19.8%
Return on equity
23.2%
Return on invested capital
78.5%
Return on capital employed
26.1%
Return on sales
33%
Dividend
Dividend yield
2.39%
DPS
$1.05
Payout ratio
81.4%

IRMD stock price

How has the Iradimed stock price performed over time
Intraday
4.87%
1 week
7.7%
1 month
9.58%
1 year
48.65%
YTD
55.32%
QTD
-0.97%

Financial performance

How have Iradimed's revenue and profit performed over time
Revenue
$62.97M
Gross profit
$47.97M
Operating income
$19.13M
Net income
$16.33M
Gross margin
76.2%
Net margin
25.9%
The company's operating income rose by 32% YoY and by 10% QoQ
Iradimed's net income has increased by 25% YoY and by 11% from the previous quarter
The company's revenue rose by 25% YoY and by 5% QoQ
The gross profit is up by 22% YoY and by 5% QoQ

Growth

What is Iradimed's growth rate over time

Valuation

What is Iradimed stock price valuation
IRMD P/E details
P/E
34.06
P/B
7.43
P/S
8.79
EV/EBIT
24.53
EV/EBITDA
24.69
EV/Sales
8.09
IRMD's price to earnings (P/E) is 47% lower than its 5-year quarterly average of 63.9 and 2.4% lower than its last 4 quarters average of 34.9
Iradimed's EPS has increased by 23% YoY and by 11% QoQ
The price to book (P/B) is 24% higher than the 5-year quarterly average of 6.0 and 3.2% higher than the last 4 quarters average of 7.2
Iradimed's equity has increased by 8% QoQ and by 7% YoY
The company's revenue rose by 25% YoY and by 5% QoQ
The price to sales (P/S) is 2.2% higher than the last 4 quarters average of 8.6

Efficiency

How efficient is Iradimed business performance
Iradimed's return on equity has increased by 20% YoY and by 9% QoQ
The company's return on assets rose by 18% YoY and by 9% QoQ
Iradimed's return on sales has increased by 14% YoY and by 6% QoQ
Iradimed's return on invested capital has decreased by 7% YoY and by 2.8% QoQ

Dividends

What is IRMD's dividend history
DPS
$1.05
Dividend yield
2.39%
Payout ratio
81.4%
Recent dividends

Financial health

How did Iradimed financials performed over time
Iradimed's quick ratio has decreased by 36% YoY
Iradimed's total liabilities has increased by 31% YoY and by 3.3% QoQ
The company's debt is 97% lower than its equity
Iradimed's equity has increased by 8% QoQ and by 7% YoY
The company's debt fell by 6% YoY and by 4.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.